131 related articles for article (PubMed ID: 38635936)
1. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.
Bhimani J; O'Connell K; Ergas IJ; Foley M; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bowles EJA; Bandera EV; Kushi LH; Kantor ED
JCO Clin Cancer Inform; 2024 Apr; 8():e2300209. PubMed ID: 38635936
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
[TBL] [Abstract][Full Text] [Related]
4. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.
Kurian AW; Lichtensztajn DY; Keegan TH; Leung RW; Shema SJ; Hershman DL; Kushi LH; Habel LA; Kolevska T; Caan BJ; Gomez SL
Breast Cancer Res Treat; 2013 Jan; 137(1):247-60. PubMed ID: 23139057
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
7. Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.
Gierach GL; Curtis RE; Pfeiffer RM; Mullooly M; Ntowe EA; Hoover RN; Nyante SJ; Feigelson HS; Glass AG; Berrington de Gonzalez A
JAMA Oncol; 2017 Feb; 3(2):186-193. PubMed ID: 27711920
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
9. Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy.
Baker K; Dunwoodie E; Jones RG; Newsham A; Johnson O; Price CP; Wolstenholme J; Leal J; McGinley P; Twelves C; Hall G
Int J Med Inform; 2017 Jul; 103():32-41. PubMed ID: 28550999
[TBL] [Abstract][Full Text] [Related]
10. Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study.
Anthony MS; Reed SD; Armstrong MA; Getahun D; Gatz JL; Saltus CW; Zhou X; Schoendorf J; Postlethwaite DA; Raine-Bennett T; Fassett MJ; Peipert JF; Ritchey ME; Ichikawa LE; Lynen R; Alabaster AL; Merchant M; Chiu VY; Shi JM; Xie F; Hui SL; Wang J; Hunter S; Bartsch J; Frenz AK; Chillemi G; Im TM; Takhar HS; Asiimwe A
Am J Obstet Gynecol; 2021 Jun; 224(6):599.e1-599.e18. PubMed ID: 33460585
[TBL] [Abstract][Full Text] [Related]
11. Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.
Denduluri N; Somerfield MR; Eisen A; Holloway JN; Hurria A; King TA; Lyman GH; Partridge AH; Telli ML; Trudeau ME; Wolff AC
J Clin Oncol; 2016 Jul; 34(20):2416-27. PubMed ID: 27091714
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Adjuvant Endocrine Therapy in Practice From Electronic Health Record Data of Patients With Breast Cancer.
Harrell M; Fabbri D; Levy M
JCO Clin Cancer Inform; 2017 Nov; 1():1-8. PubMed ID: 30657375
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
Hoon SN; Lau PK; White AM; Bulsara MK; Banks PD; Redfern AD
Cochrane Database Syst Rev; 2021 May; 5(5):CD011220. PubMed ID: 34037241
[TBL] [Abstract][Full Text] [Related]
14. Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system.
Kantor ED; O'Connell K; Ergas IJ; Valice E; Roh JM; Bhimani J; Heon N; Griggs JJ; Lee J; Bowles EJ; Rivera DR; Kolevska T; Bandera EV; Kushi LH
Breast Cancer Res Treat; 2024 Feb; 203(3):565-574. PubMed ID: 37923962
[TBL] [Abstract][Full Text] [Related]
15. Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
Williams CP; Kenzik KM; Azuero A; Williams GR; Pisu M; Halilova KI; Ingram SA; Yagnik SK; Forero A; Bhatia S; Rocque GB
Oncologist; 2019 Jan; 24(1):31-37. PubMed ID: 30120157
[TBL] [Abstract][Full Text] [Related]
16. Utilization of HER2 genetic testing in a multi-institutional observational study.
Goddard KA; Bowles EJ; Feigelson HS; Habel LA; Alford SH; McCarty CA; Nekhlyudov L; Onitilo AA; Rahm AK; Webster JA
Am J Manag Care; 2012 Nov; 18(11):704-12. PubMed ID: 23198713
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for advanced gastric cancer.
Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
[TBL] [Abstract][Full Text] [Related]
18. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]